首页> 外国专利> Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells

Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells

机译:通过DC亚洲无糖蛋白受体将抗原靶向人树突状细胞产生IL-10调节性T细胞

摘要

Compositions and methods for targeting protein antigens to human DCs via DC-asialoglycoprotein receptor (DC-ASGPR) are disclosed herein. The DC-ASGPR carries an intracellular tyrosine-based and dileucine motif, resulting in the generation of such IL-10 Tregs both in vitro and in vivo. The methods of the present invention can be used for designing vaccines against autoimmune diseases where autoantigens are defined, such as type 1 diabetes and multiple sclerosis.
机译:本文公开了用于通过DC-亚糖蛋白受体(DC-ASGPR)将蛋白抗原靶向人DC的组合物和方法。 DC-ASGPR带有基于细胞内酪氨酸和双亮氨酸的基序,从而在体外和体内均产生此类IL-10 Treg。本发明的方法可用于设计针对定义自身抗原(例如1型糖尿病和多发性硬化症)的自身免疫疾病的疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号